Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 5 July 1974:
Vol. 185. no. 4145, pp. 61 - 63
DOI: 10.1126/science.185.4145.61
Prev | Table of Contents | Next

Articles

Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man

Michael S. Brown 1 and Joseph L. Goldstein 1

1 Department of Internal Medicine, University of Texas Southwestern Medical School. Dallas 75235

Studies in ctltured fibroblasts indicate that the primary genetic abnormality in familial hypercholesterolemia involves a deficiency in a cell surface receptor for low density lipoproteins (LDL). In normal cells, binding of LDL to this receptor regulates cholesterol metabolism by suppressing cholesterol synthesis and increasing LDL degradation. In cells from heterozygotes, a 60 percent reduction in LDL receptors leads to a concentration-dependent defect in regulation, so that attainment of equal rates of cholesterol synthesis and LDL degradation in normal and heterozygous cells requires a two- to threefold higher concentration of LDL in the heterozygote. The identification of this genetic regulatory defect in fibroblasts of heterozygotes makes available an in vitro system for studying the effects of a dominant mutation on gene expression in mammalian cells.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genomics and cardiovascular drug development..
A. S. Plump and P. Y. Lum (2009)
J. Am. Coll. Cardiol. 53, 1089-1100
   Abstract »    Full Text »    PDF »
Genetic Variants Associated With Myocardial Infarction Risk Factors in Over 8000 Individuals From Five Ethnic Groups: The INTERHEART Genetics Study.
S. S. Anand, C. Xie, G. Pare, A. Montpetit, S. Rangarajan, M. J. McQueen, H. J. Cordell, B. Keavney, S. Yusuf, T. J. Hudson, et al. (2009)
Circ Cardiovasc Genet 2, 16-25
   Abstract »    Full Text »    PDF »
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review.
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries (2004)
Am. J. Epidemiol. 160, 407-420
   Abstract »    Full Text »    PDF »
Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review.
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries (2004)
Am. J. Epidemiol. 160, 421-429
   Abstract »    Full Text »    PDF »
Familial Hypercholesterolemia, Peripheral Arterial Disease, and Stroke: A HuGE Minireview.
C. M. Hutter, M. A. Austin, and S. E. Humphries (2004)
Am. J. Epidemiol. 160, 430-435
   Abstract »    Full Text »    PDF »
Bronchial endothelial cell phenotypes and the form:function relationship.
T. Stevens (2002)
Am J Physiol Lung Cell Mol Physiol 283, L518-L519
   Full Text »    PDF »
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes.
G. J. Schroepfer Jr. (2000)
Physiol Rev 80, 361-554
   Abstract »    Full Text »    PDF »
Receptor-mediated control of cholesterol metabolism.
M. Brown and J. Goldstein (1976)
Science 191, 150-154
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)